Titan Medical Set for Amalgamation After Conavi Approval
Company Announcements

Titan Medical Set for Amalgamation After Conavi Approval

Story Highlights

Titan Medical (TSE:TMD) has released an update.

Titan Medical Inc. has announced that Conavi Medical Inc.’s shareholders have unanimously approved an all-stock Amalgamation with Titan, which is expected to be a reverse takeover. The Amalgamation, highlighting confidence in their combined future and the Novasight Hybrid System, awaits Titan shareholder approval and satisfaction of closing conditions.

For further insights into TSE:TMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskTitan Medical Completes $7.7M Private Placement
TipRanks Canadian Auto-Generated NewsdeskTitan Medical Directors Resign Amidst Board Changes
TipRanks Canadian Auto-Generated NewsdeskTitan Medical Shifts to TSX Venture Exchange
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App